Autopsy report · NCT00265980
Leptin in Human Energy and Neuroendocrine Homeostasis
Cause of deathFunding or business
“Closed by sponsor. Lack of funding.”
Life of this trial
- Registered 3 years 5 months after it had already started.
- Ran for about 11 years before it stopped.
- 22 participants enrolled.
- Results were posted on the registry 6 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Columbia University
- Sponsor type
- University, hospital or other
- Conditions
- Obesity; Weight Loss
- Interventions
- Subcutaneous Placebo; Leptin
- Participants
- 22
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
“Closed by sponsor, lack of enrollment.” - Ponatinib in Advanced or Metastatic Medullary Thyroid Cancer
“Closed by sponsor” - Changes in Bone Turnover With Increased Incretin Hormone Exposure
“Study closed by sponsor. Funding ended.” - LCI Apheresis to Obtain Plasma or White Blood Cells
“Closed by the Sponsor/DSMB/IRB” - The Effect of Theraworx Foam in Carpal Tunnel Syndrome
“Lack of Funding from Sponsor”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.